Page 3 - Will Chou News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Will chou. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Will Chou Today - Breaking & Trending Today
NEW YORK and BASEL, Switzerland, June 28, 2021 /PRNewswire/ Aruvant Sciences, a private company focused on developing gene therapies for rare diseases, today announced the appointment of Stanley J. Musial as chief financial officer (CFO) effective immediately. Mr. Musial brings over twenty-five years of experience building corporate value through operational execution, financial strategy and capital fundraising. Stan s expertise in managing financials and raising capital at both private and public biotechnology companies comes at an important time as Aruvant goes through substantial growth, said Will Chou, M.D., chief executive officer of Aruvant. Stan is a critical addition to our leadership team as we put the infrastructure in place needed to support the development of our pipeline of potentially life changing gene therapies for individuals living with rare diseases. ....
Aruvant Appoints Stan Musial as Chief Financial Officer prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Aruvant Announces Oral Presentation at 15th Annual Sickle Cell Disease Research & Educational Symposium & 44th National Sickle Cell Disease Scientific Meeting prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Gene therapy for sickle cell disease shows curative potential healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Aruvant Sciences ("Aruvant"), a private company focused on developing gene therapies for rare diseases, today announced the selection of an. ....